THERAMAP - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Image for trademark with serial number 77388974
Serial Number
77388974
Word Mark
THERAMAP
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2010-01-19
Filing Date
2008-02-05
Mark Drawing
4000 - Standard character mark Typeset
Attorney Name
Law Office Assigned Location Code
M50
Employee Name
PINO, BRIAN J
Statements
Goods and Services
Advisory services relating to diagnostic preparations and products, namely, consulting and advisory services relating to prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system, consulting and advisory services relating to prediction of response of individuals to pharmaceutical products and treatments for psychiatric disorders, consulting and advisory services relating to the development, testing and efficacy, of pharmaceutical preparations and products for the treatment of diseases and disorders of the central nervous system, consulting and advisory services relating to the development, testing and efficacy, of pharmaceutical preparations and products for the treatment of Psychiatric diseases and disorders, and consulting and advisory services relating to the provision of goods containing reagents for use in the collection and testing of DNA, RNA and bodily tissues; advisory services relating to diagnostic apparatus and diagnostic instruments, namely, consulting and advisory services relating to prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system, consulting and advisory services relating to prediction of response of individuals to pharmaceutical products and treatments for psychiatric disorders, relating to apparatus and instruments used in the prediction of the response of individuals to pharmaceutical products and treatment for diseases and disorders of the central nervous system, relating to apparatus and instruments used in the prediction of the response of individuals to pharmaceutical products and treatment for psychiatric diseases and disorders, consulting and advisory services relating to the development, testing and efficacy, of apparatus and diagnostic instruments for the treatment of diseases and disorders of the central nervous system, consulting and advisory services relating to the development, testing and efficacy, of pharmaceutical preparations and products for the treatment of psychiatric diseases and disorders, in connection with assays or assay kits for use in the collection and testing of DNA, RNA and bodily tissues, and in connection with assay kits (which may contain reagents) for use in the collection of DNA, RNA and bodily tissues; design and control of pharmacogenetic diagnostic tests for prediction of response of individuals to pharmaceutical products and treatments, for disorders of the central nervous system; design and control of pharmacogenetic diagnostic tests for prediction of response of individuals to pharmaceutical products and treatments, for psychiatric disorders; design and control of pharmacogenetic diagnostic tests for disorders and diseases of the central nervous system; design and control of pharmacogenetic diagnostic tests for psychiatric diseases and disorders; design and control of pharmacogenetic tests, including the devising, compiling and testing of algorithms and mathematical systems for predicting response to a pharmaceutical product based on individual genetic profile; scientific research related to pharmacogenetics; research and advisory services relating to pharmaceuticals
Goods and Services
Medical diagnostic services; diagnostic testing relating to the human body, namely, diagnostic testing and analysis of samples, in order to predict response of individuals to pharmaceutical products and treatments for disorders of the central nervous system, diagnostic testing and analysis of samples in order to predict response of individuals to pharmaceutical products and treatments for psychiatric disorders, diagnostic testing and analysis of samples in order to confirm diagnosis of diseases and disorders of the central nervous system, and diagnostic testing and analysis of samples in order to confirm diagnosis of Psychiatric diseases and disorders; clinical services, namely, the analysis of samples of DNA, RNA and bodily tissues in order to prescribe the pharmaceutical product or treatment best suited to the patient (i.e. the pharmaceutical product likely to have the most beneficial effect and/or the one with fewest or least severe side effects), the taking of samples of bodily tissues for analysis in connection with the prescription of pharmaceuticals, or other medical treatment, and medical and scientific research in the nature of conducting clinical trials; compilation of medical reports, relating to prediction of response of individuals to pharmaceutical products and treatments for disorders of the central nervous system; compilation of medical reports, relating to confirmation of diagnosis of diseases and disorders of the body, and prescription of most efficient and efficacious pharmaceutical product or method for treatment thereof; compilation of medical reports, namely, a resource of phenotypic and genotypic data relating to diseases and disorders of the central nervous system and psychiatric diseases and disorders; conducting of medical examinations for diagnosis of treatments; testing and profiling for medical purposes; computer aided diagnostic testing services relating to the human body
Pseudo Mark
THERA GENETICS MAP
Classification Information
International Class
42 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2008-02-08
Primary Code
042
International Class
44 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2008-02-08
Primary Code
044
Correspondences
Name
Lisa A. Osman
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2007-08-306241641EMTrue
Trademark Events
Event DateEvent Description
2008-02-08NEW APPLICATION ENTERED IN TRAM
2008-02-09NOTICE OF PSEUDO MARK MAILED
2008-02-15TEAS VOLUNTARY AMENDMENT RECEIVED
2008-03-13ASSIGNED TO LIE
2008-03-19APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED
2008-04-29ASSIGNED TO EXAMINER
2008-04-30ASSIGNED TO EXAMINER
2008-05-05NON-FINAL ACTION WRITTEN
2008-05-05NON-FINAL ACTION E-MAILED
2008-05-05NOTIFICATION OF NON-FINAL ACTION E-MAILED
2008-06-06TEAS CHANGE OF CORRESPONDENCE RECEIVED
2008-11-05TEAS RESPONSE TO OFFICE ACTION RECEIVED
2008-11-07CORRESPONDENCE RECEIVED IN LAW OFFICE
2008-11-07TEAS/EMAIL CORRESPONDENCE ENTERED
2008-11-24NON-FINAL ACTION WRITTEN
2008-11-24NON-FINAL ACTION E-MAILED
2008-11-24NOTIFICATION OF NON-FINAL ACTION E-MAILED
2008-12-09TEAS RESPONSE TO OFFICE ACTION RECEIVED
2008-12-11CORRESPONDENCE RECEIVED IN LAW OFFICE
2008-12-11TEAS/EMAIL CORRESPONDENCE ENTERED
2008-12-23EXAMINERS AMENDMENT -WRITTEN
2008-12-23EXAMINERS AMENDMENT E-MAILED
2008-12-23NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2008-12-23EXAMINER'S AMENDMENT ENTERED
2008-12-23SUSPENSION LETTER WRITTEN
2008-12-23LETTER OF SUSPENSION E-MAILED
2008-12-23NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2009-06-23LIE CHECKED SUSP - TO ATTY FOR ACTION
2009-06-23SUSPENSION INQUIRY WRITTEN
2009-06-23INQUIRY TO SUSPENSION E-MAILED
2009-06-23NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
2010-01-19ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
2010-01-19ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND